Adverse Drug Reactions of Different Brands of Ceftazidime Injection

National Taiwan University

Status and phase: Unknown; Phase 4

Conditions: Infection

Treatments: Drug: ceftazidime

Study type: Interventional

Funder types: Other

Identifiers

NCT00173901

900104

Details and patient eligibility

About

The purpose of this study is to understand whether generic ceftazidime causes different adverse drug reaction incidence from the brand drug.

Full description

Ceftazidime is a third generation cephalosporins that should be reserved for severe bacterial infections. Substitution of the brand ceftazidime with a generic ceftazidime raised some concerns.

The purpose of this study is to understand whether generic ceftazidime causes different adverse drug reaction incidence from the brand drug.

Sex: All

Ages: 1 to 95 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• patients in surgical intensive care unit who require ceftazidime treatment

Exclusion criteria

• less than 1 year old

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Single Blind